Back to SANDS CAPITAL MANAGEMENT, LLC SANDS CAPITAL MANAGEMENT, LLC

RARERARE
13 quarters

Position history for SANDS CAPITAL MANAGEMENT, LLCSANDS CAPITAL MANAGEMENT, LLC's holdings in Ultragenyx Pharmaceutical, Inc.

SANDS CAPITAL MANAGEMENT, LLC holds 3.2M shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $105.5M as of 2026-Q2. The position was decreased (-1.8% shares). RARE represents 0.4% of SANDS CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$105.5M

Current Shares

3.2M

Total Value Change

-$17.9M

Total Shares Change

+484,730

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.2M
-1.8%
$105.5M0.4%$33.39
0
2026-Q1
Decreased
3.2M
-7.8%
$67.3M0.3%$22.07
0
2025-Q4
Decreased
3.5M
-7.5%
$80.2M0.2%$22.78
0
2025-Q3
Decreased
3.8M
-4.4%
$113.4M0.3%$30.36
0
2025-Q2
Decreased
3.9M
-5.3%
$143.4M0.4%$36.52
0
2025-Q1
Decreased
4.2M
-3.1%
$150.8M0.5%$37.82
0
2024-Q4
Decreased
4.3M
-16.0%
$180.8M0.5%$42.27
0
2024-Q3
Decreased
5.1M
-4.4%
$284.3M0.9%$54.43
0
2024-Q2
Increased
5.4M
+38.7%
$220.1M0.6%$41.10
57
2024-Q1
Decreased
3.9M
-6.3%
$180.2M0.5%$46.69
0
2023-Q4
Increased
4.1M
+59.8%
$196.9M0.6%$47.82
62
2023-Q3
Decreased
2.6M
-3.6%
$91.9M0.3%$35.65
0
2023-Q2
New
2.7M
-
$123.3M0.4%$46.65
50

Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used